Elan Corporation PLC : * Proposal" by royalty pharma remains an indication of interest, is highly conditional * The "proposal" by royalty pharma remains an indication of interest * Any credible proposal" which may be made by royalty pharma or any other party
Elan Corporation, plc (Elan) is a neuroscience-based biotechnology company. Shares of ELN fell by 0.08% or $-0.01/share to $11.86. In the past year, the shares have traded as low as $9.37 and as high as $15.27. On average, 5719200 shares of ELN exchange hands on a given day and today's volume is recorded at 136882.
Source
